Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Pleural Effusion, Malignant 1Mesothelioma, Malignant 1Mesothelioma 1

Interventions

pembrolizumab 9Pemetrexed 7Cyclophosphamide 6Nivolumab 5Ipilimumab 5Cisplatin 5Carboplatin 5fludarabine 4Drug Therapy 2Bevacizumab 2tremelimumab 1tocilizumab 1tazemetostat 1spartalizumab 1sotorasib 1rebastinib 1poly ICLC 1pevonedistat 1osimertinib 1milademetan 1fludarabine phosphate 1epacadostat 1durvalumab 1defactinib 1atezolizumab 1aldesleukin 1Vorinostat 1Thiostrepton 1Tablets 1Plicamycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Mesothelioma × Thiostrepton × Clear all
NCT05278975 2024-01-26

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

RS Oncology LLC

Phase 1/2 Unknown
186 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡